Nautilus Bio (NAUT) Revenue & Revenue Breakdown
Nautilus Bio Revenue Highlights
0
Latest Revenue (Q)
$6.52M
Nautilus Bio Revenue by Period
Nautilus Bio Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | - |
Nautilus Bio generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Nautilus Bio Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $6.52M | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $9.60M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $8.21M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | - |
Nautilus Bio generated $6.52M in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Nautilus Bio Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ARCT | Arcturus Therapeutics | $152.31M | $17.15M |
| ENTA | Enanta Pharmaceuticals | $65.32M | $18.31M |
| FHTX | Foghorn Therapeutics | $22.60M | $8.15M |
| PYXS | Pyxis Oncology | $16.15M | - |
| IMRX | Immuneering | - | - |
| ZURA | Zura Bio | - | - |
| TNYA | Tenaya Therapeutics | - | - |
| HUMA | Humacyte | - | $753.00K |
| NAUT | Nautilus Bio | - | $6.52M |
| ASMB | Assembly Biosciences | - | - |
| SGMT | Sagimet Biosciences | - | - |